Business Wire

Fastly Empowers Media & Entertainment Brands Across Europe With High-Performance Content at the Edge

4.12.2019 09:00:00 EET | Business Wire | Press release

Share

Fastly, Inc. (NYSE: FSLY), provider of a global edge cloud platform, today reports expanded adoption of its edge offerings and services across leading European media and entertainment brands. Fastly customers, such as Paradox Interactive, PRISA, RCS MediaGroup, and ZEIT ONLINE, employ Fastly’s high-density points of presence to power gaming, streaming or over-the-top (OTT) video, breaking news, and more as the need to support high volumes of simultaneous viewers, gamers, and readers with high-quality experiences increases.

High impact streaming and media services that prevent lag and latency are essential for brands to successfully serve a global customer base. As media companies continue to evolve from their traditional print and broadcast models, they are leveraging new services and technologies to help them scale and monetize new digital models. This evolution has allowed more viewers, gamers, and readers to access media content, but higher traffic can also lead to a host of user experience issues, including challenges associated with a sudden influx of traffic requesting the same source. Fastly’s modern network architecture and edge capabilities, like request collapsing and load balancing, help large and growing media companies support live and high volume traffic, even during spikes due to breaking news, prime gaming windows, or a big sporting event.

“Providing our customers with optimal viewing experiences is a top priority for us,” said Jorge Martin Ibarra, CTO/CIO at PRISA. “We found Fastly’s Instant Purge and DevOps capabilities, in addition to their impressive dedication to tech support, attractive in this pursuit. Our developers now enjoy the benefits of instant configuration changes and real-time control, allowing us to deliver the high-quality experience our customers have come to rely on us for.”

Amidst these increasing end user expectations for content consumption, live streaming has come into its heyday, bringing with it a new set of delivery and quality of experience challenges. For media companies that offer live streaming, Fastly’s Media Shield continues to bolster performance and availability by caching more content in high-density data centers, thereby reducing startup times and playback interruptions. Media Shield – a multi-CDN deployment optimization service that sits between a company’s CDN deployments and its central cloud or on-premise infrastructure – also reduces egress costs and total cost of ownership (TCO) by eliminating extraneous requests. The solution allows for flexible deployments, can be used with or without Fastly for edge delivery, and does not require you to re-evaluate existing contractual commitments with other CDNs.

“There have never been greater demands on media and entertainment companies to deliver dynamic content in the moment,” comments Fastly General Manager of EMEA, Gonzalo de la Vega. “That’s why we’ve been focused on providing the fast, efficient, and scalable infrastructure media companies require to deliver high-quality experiences. The edge of the internet is the best place to unlock these capabilities, where fewer but more powerful points-of-presence prove much more effective than thousands of scattered data centers.”

To learn more about Fastly’s offerings for media and entertainment companies and digital publishers, visit: https://www.fastly.com/solutions/digital-publishing and https://www.fastly.com/products/media-and-streaming.

About Fastly

Fastly helps people stay better connected with the things they love. Fastly’s edge cloud platform enables customers to create great digital experiences quickly, securely, and reliably by processing, serving, and securing our customers’ applications as close to their end-users as possible — at the edge of the internet. The platform is designed to take advantage of the modern internet, to be programmable, and to support agile software development. Fastly’s customers use our edge cloud platform to ensure concertgoers can buy tickets to the live events they love, travelers can book flights seamlessly and embark on their next great adventure, and sports fans can stream events in real-time, across devices. They include many of the world’s most prominent companies, including The New York Times, Shazam, and Ticketmaster.

This press release contains “forward-looking” statements that are based on Fastly’s beliefs and assumptions and on information currently available to Fastly on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties, and other factors that may cause its actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include, but are not limited to, those regarding the expected needs of Fastly customers, the ability for customers to innovate using Fastly and execute on new ideas in an environment that requires high levels of scale, safety and speed of delivery, and the effectiveness of fewer but more powerful points-of-presence. Except as required by law, Fastly assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Important factors that could cause Fastly’s actual results to differ materially are detailed from time to time in the reports Fastly files with the Securities and Exchange Commission (SEC), including in its quarterly report on Form 10-Q for the quarter ended September 30, 2019. Copies of reports filed with the SEC are posted on Fastly’s website and are available from Fastly without charge.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Elaine Greenberg
press@fastly.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 11:11:00 EEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye